 |
|
Long-Term Clinical Benefits of a Platelet Glycoprotein 2b/3a Receptor Blocker, Abciximab ReoProR, in High-Risk Diabetic Patients undergoing Percutaneous Coronary Intervention
Doo Sun Sim, Myung Ho Jeong, Weon Kim, Jay Young Rhew, Ju Hyup Yum, Ju Han Kim, Jeong Gwan Cho, Young Keun Ahn, Jong Chun Park, Byoung Hee Ahn, Sang Hyung Kim, Jung Chaee Kang
Korean J Intern Med. 2003;18(3):129-137. Published online 2003 Sep 1 DOI: https://doi.org/10.3904/kjim.2003.18.3.129
|
|
Citations to this article as recorded by
 In‐vitro assays of polymer‐coated stents eluting platelet glycoprotein IIb/IIIa receptor monoclonal antibody
Tieying Yin, Guixue Wang, Changgeng Ruan, Randolph Guzman, Robert Guidoin
Journal of Biomedical Materials Research Part A.2007; 83A(3): 861. CrossRef Predictive Factors for the Recovery of Left Ventricular Dysfunction in Patients with Acute Myocardial Infarction
Sang Chun Lim, Jung Ae Rhee, Myung Ho Jeong, Jin Soo Choi, Eun Suk Shin, Kye Hun Kim, Ju Han Kim, Jae Youn Moon, Young Joon Hong, Young Keun Ahn, Jeong Gwang Cho, Jong Chun Park, Jung Chaee Kang
Korean Circulation Journal.2007; 37(3): 113. CrossRef
|